Aleksander Perzynski-Salomon

Warsaw, MZ 02776, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Characterization and Experimental Use of Multiple Myeloma Bone Marrow Endothelial Cells and Progenitors.

Characterization and Experimental Use of Multiple Myeloma Bone Marrow Endothelial Cells and Progenitors.

Journal: International journal of molecular sciences

Published: October 05, 2024

CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma.

CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma.

Journal: Cancers

Published: August 30, 2022

Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model.

Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model.

Journal: Clinical and experimental medicine

Published: June 20, 2022

Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing.

Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing.

Journal: Biomedicines

Published: June 11, 2022

SARS-CoV-2 Infection in Patients Treated with Azacitidine and Venetoclax for Acute Leukemia: A Report of a Case Series Treated in a Single Institution.

SARS-CoV-2 Infection in Patients Treated with Azacitidine and Venetoclax for Acute Leukemia: A Report of a Case Series Treated in a Single Institution.

Journal: Chemotherapy

Published: March 14, 2022

A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia.

A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia.

Journal: Frontiers in immunology

Published: September 22, 2021

Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications.

Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications.

Journal: Diagnostics (Basel, Switzerland)

Published: July 29, 2021

Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG).

Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG).

Journal: Cancers

Published: June 28, 2021

The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients.

The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients.

Journal: Journal of clinical medicine

Published: May 30, 2021

POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis.

POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 27, 2021

The management of hematologic malignancies during the COVID-19 pandemic.

The management of hematologic malignancies during the COVID-19 pandemic.

Journal: Expert opinion on pharmacotherapy

Published: December 21, 2020

The impact of cytogenetic evolution and acquisition of del(17p) on the prognosis of patients with multiple myeloma.

The impact of cytogenetic evolution and acquisition of del(17p) on the prognosis of patients with multiple myeloma.

Journal: Polish archives of internal medicine

Published: April 28, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026